클리어마인드 메디슨(CMND)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.86 (+0.54%), 시가총액 $0.00B, 52주 범위 $0.07 ~ $2.80.
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a collaboration with Sci
클리어마인드 메디슨의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
클리어마인드 메디슨의 현재 주가는 $1.86 (+0.54%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
클리어마인드 메디슨의 시가총액은 약 $0.00B입니다.
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders,